Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05422521
NA

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

Sponsor: Centre Hospitalier Universitaire de Nice

View on ClinicalTrials.gov

Summary

This is an interventionnal pilot study to investigate whether 18FDG radiomics or serum metabolomic signatures could be predictive or prognostic factors in the follow-up of patients receiving CAR T-cell therapy for refractory non-Hodgkin's lymphoma or in relapse.

Official title: Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma: Pilot Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2022-08-29

Completion Date

2025-12-10

Last Updated

2026-06-17

Healthy Volunteers

No

Interventions

OTHER

blood samples and 18FDG PET-CT exams

* 18 FDG PET scanner at inclusion and post CART-cells treatment ( 1, 3, 6, 9 and 12 month) * blood collection at inclusion and post CART-cells treatment (7 days, 1 month and 3 month)

Locations (1)

CHU de Nice

Nice, France